Co-Diagnostics, Inc.

Research Co-Diagnostics, Inc. (0A50) on Bullrun: P/E 2.4. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker0A50
• ExchangeLSE
• CountryUnited States
• CurrencyUSD
• P/E2.4

Valuation Snapshot

P/E is 2.4.

About Co-Diagnostics, Inc.

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting.

Frequently asked questions

What is Co-Diagnostics, Inc.'s P/E ratio?

Co-Diagnostics, Inc.'s price-to-earnings (P/E) ratio is 2.4.

What does Co-Diagnostics, Inc. do?

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.